title: Advances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumors.
abstract: Medulloblastoma and central nervous system (CNS)-primitive neuro-ectodermal tumors (PNETs) are a diverse group of entities which encompasses different pathological and clinical pictures. Initially divided based on histology and location, molecular insight is leading to new definitions and a change in the borders delineating these diseases, such that they become more divergent. Current treatment approaches consist of surgical resection, radiotherapy and intensive chemotherapy, dependent on age. Stratification is one risk factor shown to be prognostic and is divided into high- and average-risks. Outcomes with modern treatment regimens are good, particularly in average-risk medulloblastoma patients, but the cost of cure is high, with high rates of neurocognitive, endocrine and social dysfunction. The changing biological landscape, however, may allow for clearer prediction of tumor behavior, to better identify "good" and "bad" players within these groups. Discovery of subgroups with changes in dependent molecular pathways will also lead to the development of new specific targeted therapies. Presenting exciting opportunities, these advances may transform the treatment for some patients, revolutionizing therapy in the future. Several challenges, however, are yet to be faced and caution is needed not to abandon previously defined prognostic factors on the strength of thus far retrospective evidence. We are witnessing a new era of trials with biological stratification involving multiple subgroups and treatment arms, based on specific tumor-related targets. This review discusses the changing face of medulloblastoma and CNS-PNETs and how we move molecular advances into clinical trials that benefit patients.
authors.affiliation: Division of Haematology/Oncology, The Hospital for Sick Children 555 University Avenue Toronto, Ontario M5G 1X8 Canada.
authors.forename: Jenny
authors.initials: J
authors.lastname: Adamski
authors.affiliation: Arthur and Sonia Labatt Brain Tumour Research Centre, Brain Tumour Research Centre, TMDT 101 College St., 11-701 Toronto, Ontario M5G 1L7 Canada.
authors.forename: Vijay
authors.initials: V
authors.lastname: Ramaswamy
authors.affiliation: Division of Haematology/Oncology, The Hospital for Sick Children 555 University Avenue Toronto, Ontario M5G 1X8 Canada ; Arthur and Sonia Labatt Brain Tumour Research Centre, Brain Tumour Research Centre, TMDT 101 College St., 11-701 Toronto, Ontario M5G 1L7 Canada.
authors.forename: Annie
authors.initials: A
authors.lastname: Huang
authors.affiliation: Division of Haematology/Oncology, The Hospital for Sick Children 555 University Avenue Toronto, Ontario M5G 1X8 Canada.
authors.forename: Eric
authors.initials: E
authors.lastname: Bouffet